Can-Fite BioPharma Statistics
Share Statistics
Can-Fite BioPharma has 44.7K
shares outstanding. The number of shares has increased by 62.34%
in one year.
Shares Outstanding | 44.7K |
Shares Change (YoY) | 62.34% |
Shares Change (QoQ) | 0% |
Owned by Institutions (%) | 1.57% |
Shares Floating | n/a |
Failed to Deliver (FTD) Shares | 1,986 |
FTD / Avg. Volume | 0.69% |
Short Selling Information
The latest short interest is 307.99K, so 2.4% of the outstanding
shares have been sold short.
Short Interest | 307.99K |
Short % of Shares Out | 2.4% |
Short % of Float | 2.4% |
Short Ratio (days to cover) | 1.49 |
Valuation Ratios
The PE ratio is -0.01 and the forward
PE ratio is -34.67.
Can-Fite BioPharma's PEG ratio is
0.
PE Ratio | -0.01 |
Forward PE | -34.67 |
PS Ratio | 0.06 |
Forward PS | 0 |
PB Ratio | 0.01 |
P/FCF Ratio | -0.01 |
PEG Ratio | 0 |
Financial Ratio History Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Can-Fite BioPharma.
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.38,
with a Debt / Equity ratio of 0.02.
Current Ratio | 4.38 |
Quick Ratio | 4.38 |
Debt / Equity | 0.02 |
Debt / EBITDA | -0.01 |
Debt / FCF | -0.01 |
Interest Coverage | -580.71 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity | n/a |
Return on Assets | n/a |
Return on Invested Capital | n/a |
Revenue Per Employee | $134,800 |
Profits Per Employee | $-1,576,000 |
Employee Count | 5 |
Asset Turnover | 0.07 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -57.38% in the
last 52 weeks. The beta is 0.25, so Can-Fite BioPharma's
price volatility has been higher than the market average.
Beta | 0.25 |
52-Week Price Change | -57.38% |
50-Day Moving Average | 1.31 |
200-Day Moving Average | 1.8 |
Relative Strength Index (RSI) | 37.42 |
Average Volume (20 Days) | 289,119 |
Income Statement
In the last 12 months, Can-Fite BioPharma had revenue of 674K
and earned -7.88M
in profits. Earnings per share was -32592.
Revenue | 674K |
Gross Profit | 674K |
Operating Income | -8.13M |
Net Income | -7.88M |
EBITDA | -8.12M |
EBIT | -8.13M |
Earnings Per Share (EPS) | -32592 |
Full Income Statement Balance Sheet
The company has 4.83M in cash and 104K in
debt, giving a net cash position of 4.72M.
Cash & Cash Equivalents | 4.83M |
Total Debt | 104K |
Net Cash | 4.72M |
Retained Earnings | -166.36M |
Total Assets | 9.12M |
Working Capital | 6.93M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -7.64M
and capital expenditures -5K, giving a free cash flow of -7.64M.
Operating Cash Flow | -7.64M |
Capital Expenditures | -5K |
Free Cash Flow | -7.64M |
FCF Per Share | -1.05 |
Full Cash Flow Statement Margins
Gross margin is 100%, with operating and profit margins of -1206.23% and -1169.14%.
Gross Margin | 100% |
Operating Margin | -1206.23% |
Pretax Margin | -1169.14% |
Profit Margin | -1169.14% |
EBITDA Margin | -1205.19% |
EBIT Margin | -1206.23% |
FCF Margin | -1133.83% |